Early-onset Alzheimer's disease with presenilin-1 M139V mutation: Clinical, neuropsychological and neuropathological study

European Journal of Neurology

Volumn 10, Issue 3, 2003, Pages 319-323

  Larner, A J ^a   Du Plessis, D G ^a  

^a WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Alzheimer's disease; M139V; Presenilin 1 mutation

Indexed keywords

PRESENILIN 1;

ADULT; ALZHEIMER DISEASE; ARTICLE; BASAL GANGLION; CASE REPORT; CEREBELLUM; CLINICAL FEATURE; GENE MUTATION; HEREDITY; HUMAN; MALE; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; SKILL; THALAMUS;

ALZHEIMER DISEASE; CEREBELLAR CORTEX; CEREBRAL CORTEX; HUMANS; MALE; MEMBRANE PROTEINS; METHIONINE; MIDDLE AGED; MUTATION; PHENOTYPE; PRESENILIN-1; THALAMUS; VALINE;

EID: 0038293423     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.2003.00597.x     Document Type: Article

References (27)

1. Alzheimer's Disease Collaborative Group (1995). The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. Nature Genet 11:219-222.
2. Boteva K, Vitek M, Mitsuda H et al. (1996). Mutation analysis of presenilin 1 gene in Alzheimer's disease. Lancet 347:130-131.
3. Braak H, Braak E (1991). Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berlin) 82:239-259.
4. Campion D, Flaman J-M, Brice A et al. (1995). Mutations of the presenilin 1 gene in families with early-onset Alzheimer's disease. Hum Mol Genet 4:2373-2377.
5. Crook R, Verkkoniemi A, Perez-Tur J et al. (1998). A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. Nature Med 4:452-455.
6. Dumanchin C, Brice A, Campion D et al., for the French Alzheimer's Disease Study Group (1998). De novo presenilin 1 mutations are rare in clinically sporadic, early onset Alzheimer's disease cases. J Med Genet 35:672-673.
7. Finckh U, Muller-Thomsen T, Mann U et al. (2000). High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analysis of four different genes. Am J Hum Genet 66:110-117.
8. Fox NC, Kennedy AM, Harvey RJ et al. (1997). Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene. Pedigree but not mutation specific age at onset provides evidence for a further genetic factor. Brain 120:491-501.
9. Gómez-Isla T, Growdon WB, McNamara MJ et al. (1999). The impact of different presenilin 1 and presenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors. Brain 122:1709-1719.
10. Gustafson L, Brun A, Englund E et al. (1998). A 50-year perspective of a family with chromosome-14-linked Alzheimer's disease. Hum Genet 102:253-257.
11. Haltia M, Viitanen M, Sulkava R et al. (1994). Chromosome 14-encoded Alzheimer's disease: genetic and clinicopathological description. Ann Neurol 36:362-367.
12. Harvey RJ, Ellison D, Hardy J et al. (1998). Chromosome 14 familial Alzheimer's disease: the clinical and neuropathological characteristics of a family with a leucine serine (L250S) substitution at codon 250 of the presenilin 1 gene. J Neurol Neurosurg Psychiatry 64:44-49.
13. Hüll M, Fiebich BL, Dykierek P et al. (1998). Early-onset Alzheimer's disease due to mutations of the presenilin-1 gene on chromosome 14: a 7-year follow-up of a patient with a mutation at codon 139. Eur Arch Psychiatry Clin Neurosci 248:123-129.
14. Ikeda M, Sharma V, Sumi SM et al. (1996). The clinical phenotype of two missense mutations in the presenilin 1 gene in Japanese patients. Ann Neurol 40:912-917.
15. Janssen JC, Lantos PL, Fox NC et al. (2001). Autopsy-confirmed familial early-onset Alzheimer's disease caused by the L153V presenilin 1 mutation. Arch Neurol 58:953-958.
16. Larner AJ (1997). The cerebellum in Alzheimer's disease: a review. Dement Geriat Cogn Disord 8:203-209.
17. Lemere CA, Lopera F, Kosik KS et al. (1996). The E280A presenilin 1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology. Nature Med 2:1146-1150.
18. Lopera F, Ardilla A, Martinez A et al. (1997). Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation. JAMA 277:793-799.
19. Mirra SS, Heyman A, McKeel D et al. (1991). The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479-486.
20. National Institute on Aging and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease (1997). Consensus recommendations for the post-mortem diagnosis of Alzheimer's disease. Neurobiol Aging 18:S1-S2.
21. Sandbrink R, Zhang D, Schaeffer S et al. (1996). Missense mutations of the PS-1/S182 gene in German early-onset Alzheimer's disease patients. Ann Neurol 40:265-266.
22. Sherrington R, Rogaev EI, Liang Y et al. (1995). Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375:754-760.
23. Smith MJ, Kwok JB, McLean CA et al. (2001). Variable phenotype of Alzhemier's disease with spastic paraparesis. Ann Neurol 49:125-129.
24. Takao M, Piccardo P, Murrell J et al. (2002). Neuropathological heterogeneity associated with presenilin 1 gene mutations. Neurobiol Aging 23:S417 (abstract 1533).
25. Verkkoniemi A, Kalimo H, Paetau A et al. (2001). Variant Alzheimer disease with spastic paraparesis: neuropathological phenotype. J Neuropathol Exp Neurol 60:483-492.
26. Warrington EK, Agnew SK, Kennedy AM, Rossor MN (2001). Neuropsychological profiles of familial Alzheimer's disease associated with mutations in the presenilin 1 and amyloid precursor protein genes. J Neurol 248:45-50.
27. Yasuda M, Maeda S, Kawamata T et al. (2000). Novel presenilin-1 mutation with widespread cortical amyloid deposition but limited cerebral amyloid angiopathy. J Neurol Neurosurg Psychiatry 68:220-223.